(Q79844178)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Daniel L Beckles

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Eduardo Mascareno

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

M A Q Siddiqui

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

23 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

350-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Hypertrophy of the heart: a new therapeutic target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Distinct components of Janus kinase/signal transducer and activator of transcription signaling pathway mediate the regulation of systemic and tissue localized renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Mechanotransduction in cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

The role of Jak/STAT signaling in heart tissue renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Cytoplasmic signaling pathways that regulate cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Jak2 Tyrosine Kinase Mediates Angiotensin II-dependent Inactivation of ERK2 via Induction of Mitogen-activated Protein Kinase Phosphatase 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Jak2 tyrosine kinase: a true jak of all trades?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Myocyte hypertrophy and apoptosis: a balancing act.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Interleukin-11 induces complex formation of Grb2, Fyn, and JAK2 in 3T3L1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.05.006

10.1016/J.VPH.2006.05.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822720%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference